Intelligent Therapeutics

CA - La JollaBiotechnology1 H-1B visas (FY2023)

Focus: Intelligent Therapeutics is a La Jolla-based biotechnology company specializing in antibodies and antibody-like molecules across cardiovascular, oncology, infectious disease, respiratory, and neurology indications. Company scale, founding date, and employee count are undisclosed.

Cardiovascular Oncology Infectious Diseases Respiratory

Profile data last refreshed Yesterday · AI intelligence enriched 2w ago

Open Jobs

About Intelligent Therapeutics

AI assessmentNot Hiring

No open roles listed right now. Follow Intelligent Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.

Why Work Here

Data completeness

1/9 — Limited

Company HealthSolid

Pipeline

Early-stage

36 total

LOE Risk

Protected

No near-term cliffs

Hiring

0 open

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

mSMART

Nicotine Dependence

N/A

Clinical Trials (1)

NCT02635919Stage Ib Trial of mSMART for Smoking Cessation Medication Adherence

N/A

Help build intelligence for Intelligent Therapeutics

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Broad therapeutic focus across five major disease areas (cardiovascular, oncology, infectious disease, respiratory, neurology) provides diverse career development opportunities
Active clinical pipeline with Phase 1/2 programs in high-value oncology (METR-NK cell for ovarian cancer) and emerging digital health applications
La Jolla location in established biotech hub with access to UCSD ecosystem and regional talent network

Watch Out For

Company appears pre-revenue with no disclosed financials, funding, or employee headcount—high execution risk and limited visibility into runway
Pipeline quality concerns: majority of 30 listed programs lack traditional drug development phase designations and appear to include clinical studies, diagnostic tools, and software rather than core therapeutic programs; only 4 programs in Phase 1/2
Zero active job postings at time of data collection; H1B sponsorship minimal (1 approval in 2023) suggesting limited hiring capacity or visa support

Generated by Claude from Intelligent Therapeutics's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Laevo ®

Passive Upper-limb Exoskeleton

N/A

Clinical Trials (1)

NCT03725982Work Physiological-Biomechanical Analysis of a Passive Exoskeleton to Support Occupational Lifting and Flexing Processes

N/A

No Intervention Provided

Autism Spectrum Disorder

N/A

Clinical Trials (1)

NCT03971578Screening for Autism Spectrum Disorders Using Auditory Brainstem Responses

N/A

Prediction of Difficult Mask Ventilation Using 3D-Facescan and Machine Learning

Mask Ventilation

N/A

prescription drug-abuse education smartphone application

Prescription Drug Abuse (Not Dependent)

N/A

Clinical Trials (1)

NCT03165175Mobile Application for Prescription Drug-Abuse Education (MAPDE)

N/A

Dehydration

N/A

Clinical Trials (1)

NCT01124903Human Hydration Status Monitoring

N/A

PrEP Smart app

At Risk for HIV

N/A

Clinical Trials (1)

NCT03080597PrEP for HBCUs (Study 2)

N/A

AI Controlled General Anesthesia

Anesthesia Induction

N/A

Clinical Trials (1)

NCT06857344Reinforcement Learned Automatic Anesthesia System During Painless Gastrointestinal Endoscopy

N/A

Hyperspectral Imaging

Lung Neoplasm

N/A

Clinical Trials (1)

NCT05676788HSI for Intersegmental Plane Identification During Sublobar Pulmonary Resections

N/A

Artificial intelligence-assisted chest X-ray in TB screening

Tuberculosis (TB)

N/A

Retinal Implant System

Retinitis Pigmentosa

N/A

Clinical Trials (1)

NCT00427180IRIS PILOT - Extended Pilot Study With a Retinal Implant System

N/A

Resynk VR session

Stroke

N/A

Clinical Trials (1)

NCT07032155Virtual Reality in Occupational Therapy Upper Limb Stroke Rehabilitation

N/A

AngioQFA

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT06039748Angiography-Derived Quantitative Functional Assessment Versus Pressure-Derived FFR and IMR: The FAIR Study

N/A

Intelligent Fingerprinting Drug Screening System

Pharmacokinetics

N/A

Clinical Trials (1)

NCT06519045PK of Codeine and Metabolites in Human Fingerprint Sweat, Oral Fluid, Blood and Urine

N/A

Arch EchoTM Intracardiac Ultrasound catheter and ultrasound system

Structural Heart Diseases

N/A

Clinical Trials (1)

NCT06344494Cardiac Interventional ICE Imaging Trial

N/A

no intervention

Postoperative Delirium

N/A

Clinical Trials (1)

NCT06423547Risk Warning Model of Postoperative Delirium and Long-term Cognitive Dysfunction in Elderly Patients

N/A

mSMART smartphone application

Cigarette Smoking

N/A

Clinical Trials (1)

NCT02072005Mobile App Based Personalized Solutions and Tools for Medication Adherence of Rx Pills

N/A

Fingerprint sweat drug screen

Reagent Kits, Diagnostic

N/A

Clinical Trials (1)

NCT06618183Drug Screening System Method Comparison

N/A

Using an electrical stimulation device to relieve pain during colonoscopy

Colonoscopy

N/A

Clinical Trials (1)

NCT06813703Analysis of the Analgesic Mechanism of TENS-WAA During Non-anesthetized Colonoscopy Using EEG-fNIRS System

N/A

ChatGPT-4

Preoperative Care

N/A

Clinical Trials (1)

NCT05945004ChatGPT v.s. Human in Writing a Preoperative Visit Sheet

N/A

AI Controlled General Anesthesia

Painless Abortion

N/A

Clinical Trials (1)

NCT07132151Reinforcement Learned Automated Anesthesia Systems During Painless Abortion

N/A

mobile internet survey on self-test

Susceptibility to Viral and Mycobacterial Infection

N/A

Biopsies using Apollo and UroStation®

Prostate Cancer

N/A

Clinical Trials (1)

NCT02132975Motorised Probe Holder Assisting Prostate Biopsies

N/A

RuiXin-CoronaryAI software

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05320185Evaluation on the Effectiveness and Safety of RuiXin-CoronaryAI for Diagnosis of Coronary Artery Stenosis

N/A

Dexmedetomidine

N/A

Clinical Trials (1)

NCT05952050Different Administration Routes of Dexmedetomidine on Postoperative Delirium

N/A

Medial-Olivocochlear Reflex

Neonatal Hearing Loss

N/A

Clinical Trials (1)

NCT04749524Otoacoustic Emission Suppression Study

N/A

VRS100 robotic-assisted PCI

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT06032572Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)

N/A

CT-FFR

Coronary Artery Disease

N/A

Clinical Trials (1)

NCT05593120Evaluation of Health Economics for Noninvasive Coronary Fractional Flow Reserve Measurement Technology

N/A

Breathing guided exercise

Chronic Obstructive Pulmonary Disease

N/A

Clinical Trials (1)

NCT06963333Clinical Study on Improving Exercise Capacity in Chronic Obstructive Pulmonary Disease Through Smart IoT-Remote Home Breathing Guidance

N/A

The Oxford Risk Factors And Non-Invasive Imaging Study

Cardiovascular Diseases

N/A

Clinical Trials (1)

NCT05169333The Oxford Risk Factors And Non-Invasive Imaging Study

N/A

Dexmedetomidine injection

Delirium in Old Age

N/A

Clinical Trials (1)

NCT06382961Postoperative Dexmedetomidine in Prevention of Postoperative Delirium

N/A

PrEP Smart

At Risk for HIV

Phase 1

Clinical Trials (1)

NCT02895893PrEP SMART Phase I Trial

Phase 1

mSMART

Nicotine Dependence

Phase 1

Clinical Trials (1)

NCT03069768Stage Ib Trial of mSMART With Varenicline

Phase 1

METR-NK cell

Ovarian Cancer

Phase 1/2

Clinical Trials (1)

NCT06395844Safety and Efficacy of Intraperitoneal Injection of METR-NK Cells as Neoadjuvant Therapy for Advanced Epithelial Ovarian Cancer

Phase 1/2

METR-NK cell（metabolic remodeling nature killer cells）

Ovary Cancer

Phase 1/2

Clinical Trials (1)

NCT07096583An Exploratory Study on NK Cell-assisted Prevention of Bone Marrow Suppression During Chemotherapy for Ovarian Cancer

Phase 1/2

Open Jobs (0)

No open positions listed yet.

Interview Prep Quick Facts

Portfolio: 32 clinical trials

Top TAs: Cardiovascular, Oncology, Infectious Diseases

H-1B (2023): 1 approval

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Therapeutic Area Focus

5 pipeline

4 pipeline

2 pipeline

1 pipeline

1 pipeline

Marketed

Pipeline

Visa Sponsorship

Sponsors Work Visas

H-1B Petitions (FY2023)

Approved

Denied

100%

Rate

Source: USCIS H-1B Employer Data Hub